Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2009-10-20 to 2009-11-24
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Details on test material:
- Name of test material : sinter ore
- Substance type: Dark grey rocks
- Physical state: solid
- Major and minor elements: (Mean) Mn 45.9 %, Fe 4.0 %, SiO2 6.5 %, Al2O3 0.583 %, P 0.020 %, MgO 3.7 %, Cao 15.5 %, S 0.03 %
Trace elements: As 8 ppm, B 585 ppm, Co 60 ppm, Cr 60 ppm, Cu 9 ppm, K2O 733 ppm, Na 0.1 %, Ni 25 ppm, Pb < 5 ppm, SrO 0.02 %, TiO2 270 ppm, Zn 60 ppm.
- Purity test date: September 2007
- Storage condition of test material: Room temperature in the dark

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratories UK, Ltd. Bicester, Oxon, UK
- Age at study initiation: 8 to 12 weeks
- Weight at study initiation: The bodyweight variation did not exceed ± 20 % of the initial/mean bodyweight of any previously dosed animals.
- Fasting period before study: Overnight fasting prior to dosing, and 3 to 4 hours post dosing.
- Housing: Animals were housed in groups of up to four in suspended solid-floor polypropylene cages furnished with woodflakes.
- Diet : 2014 Teklad Global Rodent diet supplied by Harlan Teklad Blackthorn (Bicester, Oxon, UK) available ad libitum
- Water : Mains tap water available ad libitum
- Acclimation period: A minimum of 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25 °C
- Humidity (%): 30 to 70 %
- Air changes (per hr): A minimum of 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hour cycle

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 30 mg/mL at the 200 mg/kg dose level and 200 mg/mL at the 2000 mg/kg dose level.
- Amount of vehicle (if gavage): 10 mL/kg
Doses:
300 and 2000 mg/kg in the sighting study and 2000 mg/kg in the main test.
No. of animals per sex per dose:
1 animal in each of the sighting dose levels, and 4 animals in the main test.
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were weighed on days 0 and 7. Clinical observations were made at 30 minutes, then 1, 2 and 4 hours post dosing and then daily for fourteen days. Morbidity and mortality checks were made twice daily.
- Necropsy of survivors performed: yes, animals were killed by cervical dislocation at the end of the 14 day observation period
- Other examinations performed: clinical signs, body weight and histopathology
Statistics:
Data evaluations included the relationship (if any were noted) between the animal's exposure to the test material and the incidence and severity of all abnormalities including behavioural and clinical observations, gross lesions, bodyweight changes, mortality and any other toxicological effects. If possible the signs of evident toxicity were also identified. Evident toxicity is defined as the toxic effects which are of a severity such that administration at the next highest level could result in mortality.

Using mortality data, an estimate of the acute oral median lethal dose (LD50) of the test material was made.

Results and discussion

Preliminary study:
At both levels of dosing in the sighting study, all animals showed expected bodyweight gains over the observation period. No signs of systemic toxicity were noted, and at necropsy.
Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Remarks on result:
other: No signs of toxicity were observed at either dose level
Mortality:
No unscheduled deaths occurred during the course of the study.
Clinical signs:
No systemic signs of toxicity were noted during the study.
Body weight:
All animals exhibited expected bodyweight gains throughout the course of the study.
Gross pathology:
No macroscopic abnormalities were noted at necropsy.
Other findings:
Not reported

Any other information on results incl. tables

 

Dose Level mg/kg

Animal No.

Effects Noted After Dosing (Hrs)

Effects Noted Post Dosing (Days)

½

1

2

4

1

2

3

4

5

6

7

8

9

10

11

12

13

14

 

300

1-0 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

 

 

Table 2: Bodyweight and Bodyweight Changes, Dose Level 300 mg/kg

 

Dose Level mg/kg

Animal No.

Bodyweight (g) on Day

Bodyweight Gain (g) During Week

0

7

14

1

2

300

1-0 Female

181

195

212

14

17

 

Table 3: Necropsy Findings, Dose level 300 mg/kg

 

Dose Level mg/kg

Animal No.

Time of Death

Macroscopic Observations

300

1-0 Female

Killed Day 14

No abnormalities detected

 

Table 4: Clinical Observations and Mortality Data, Dose Level 2,000 mg/kg

Dose Level mg/kg

Animal No.

Effects Noted After Dosing (Hrs)

Effects Noted Post Dosing (Days)

½

1

2

4

1

2

3

4

5

6

7

8

9

10

11

12

13

14

2,000

2-0 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3-0 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3-1 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3-2 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3-3 Female

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

 

Table 5: Bodyweight and Bodyweight Changes, Dose Level 2,000 mg/kg

 

Dose Level mg/kg

Animal No.

Bodyweight (g) on Day

Bodyweight Gain (g) During Week

0

7

14

1

2

2,000

2-0 Female

159

164

165

5

1

3-0 Female

160

170

176

10

6

3-1 Female

197

212

216

15

4

3-2 Female

190

206

208

16

2

3-3 Female

160

168

178

8

10

 

Table 6: Necropsy Findings, Dose level 2,000 mg/kg

 

Dose Level mg/kg

Animal No.

Time of Death

Macroscopic Observations

2,000

2-0 Female

Killed Day 14

No abnormalities detected

3-0 Female

Killed Day 14

No abnormalities detected

3-1 Female

Killed Day 14

No abnormalities detected

3-2 Female

Killed Day 14

No abnormalities detected

3-3 Female

Killed Day 14

No abnormalities detected

Applicant's summary and conclusion

Interpretation of results:
other: Not classified in accordance with EU criteria.
Conclusions:
Under the conditions of the test, the acute oral LD50 of sinter ore was estimated to be greater than 2000 mg/kg in female Wistar rats.
Executive summary:

The acute oral toxicity of the test material was investigated in a study which was conducted in accordance with the standardised guidelines OECD 420 and EU Method B.1 Bis, and under GLP conditions.

Under the conditions of the test, the acute oral LD50 of sinter ore was estimated to be greater than 2000 mg/kg in female Wistar rats.